Long-Term Efficacy of Vedolizumab in Pediatric Inflammatory Bowel Disease

被引：0
|
作者：
Sarles, Harry E., Jr.
Whitney, Annette E.
Kuten, Samantha A.
Van Anglen, Lucinda J.
机构：
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000594116.32306.0b
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1147
引用
收藏
页码：S643 / S644
页数：2
相关论文
共 50 条
  • [1] Long-term safety of vedolizumab for inflammatory bowel disease
    Loftus, Edward V., Jr.
    Feagan, Brian G.
    Panaccione, Remo
    Colombel, Jean-Frederic
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert
    Rubin, David T.
    Shafran, Ira
    Parfionovas, Andrejus
    Rogers, Raquel
    Lirio, Richard A.
    Vermeire, Severine
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1353 - 1365
  • [2] SINGLE CENTER EXPERIENCE OF LONG TERM VEDOLIZUMAB EFFICACY IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Singh, Namita
    Dubinsky, Marla
    Singh, Avantika
    Check, Morgan
    Rabizadeh, Shervin
    GASTROENTEROLOGY, 2017, 152 (05) : S959 - S960
  • [3] An update on the safety of long-term vedolizumab use in inflammatory bowel disease
    Honap, Sailish
    Netter, Patrick
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON DRUG SAFETY, 2023,
  • [4] Long-term Clinical Experience with Vedolizumab in Patients with Inflammatory Bowel Disease
    Parikh, Asit
    Fox, Irving
    Leach, Timothy
    Xu, Jing
    Scholz, Catherine
    Patella, Michael
    Feagan, Brian G.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (08) : 1691 - 1699
  • [5] An update on the safety of long-term vedolizumab use in inflammatory bowel disease
    Honap, Sailish
    Netter, Patrick
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (09) : 767 - 776
  • [6] Long-term outcomes of pediatric inflammatory bowel disease
    Nasiri, Soheila
    Kuenzig, Mary Ellen
    Benchimol, Eric I.
    SEMINARS IN PEDIATRIC SURGERY, 2017, 26 (06) : 398 - 404
  • [7] Vedolizumab Immunogenicity With Long-Term or Interrupted Treatment of Patients With Inflammatory Bowel Disease
    Wyant, Timothy
    Yang, Lili
    Lirio, Richard A.
    Rosario, Maria
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (09): : 1174 - 1181
  • [8] Thioguanine in inflammatory bowel disease: Long-term efficacy and safety
    Ward, Mark G.
    Patel, Kamal V.
    Kariyawasam, Viraj C.
    Goel, Rishi
    Warner, Ben
    Elliott, Tim R.
    Blaker, Paul A.
    Irving, Peter M.
    Marinaki, Anthony M.
    Sanderson, Jeremy D.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (04) : 563 - 570
  • [9] Long-term Efficacy of Vedolizumab for Crohn's Disease
    Vermeire, Severine
    Loftus, Edward V., Jr.
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert R.
    Kaser, Arthur
    Panaccione, Remo
    Rubin, David T.
    Shafran, Ira
    McAuliffe, Megan
    Kaviya, Arpeat
    Sankoh, Serap
    Mody, Reema
    Abhyankar, Brihad
    Smyth, Michael
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (04): : 412 - 424
  • [10] Correlation of vedolizumab levels with medium-and long-term response in patients with Inflammatory Bowel Disease
    Hernandez-Perez, M.
    Ferrer, C. J. Suarez
    Garcia-Ramirez, L.
    Martinarranz, E.
    Sanchezazofra, M.
    Cordon, J. Poza
    Garcia, J. L. Rueda
    Martin-Arranz, M. D.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1992 - i1993
12345